ASX - By Stock
|
BOD |
Re:
Ann: Convening of Second Meeting of Creditors
|
|
BH31
|
8 |
3.1K |
0 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
8
|
3.1K
|
0
|
|
ASX - By Stock
|
BOD |
Re:
Ann: Convening of Second Meeting of Creditors
|
|
BH31
|
8 |
3.1K |
1 |
30/03/24 |
30/03/24 |
ASX - By Stock
|
8
|
3.1K
|
1
|
|
ASX - By Stock
|
BOD |
Re:
Ann: Convening of Second Meeting of Creditors
|
|
BH31
|
8 |
3.1K |
0 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
8
|
3.1K
|
0
|
|
ASX - By Stock
|
BOD |
Re:
Ann: Further delay in lodgement of App.4D and Half Year Report
|
|
BH31
|
3 |
1.0K |
0 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
3
|
1.0K
|
0
|
|
ASX - By Stock
|
OJC |
Re:
Ann: Placement
|
|
BH31
|
33 |
14K |
1 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
33
|
14K
|
1
|
|
ASX - By Stock
|
BOD |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
BH31
|
5 |
1.7K |
3 |
30/01/24 |
30/01/24 |
ASX - By Stock
|
5
|
1.7K
|
3
|
|
ASX - By Stock
|
OJC |
Re:
Ann: Placement
|
|
BH31
|
33 |
14K |
6 |
25/01/24 |
25/01/24 |
ASX - By Stock
|
33
|
14K
|
6
|
|
ASX - By Stock
|
OJC |
Re:
Ann: Notice of initial substantial holder
|
|
BH31
|
9 |
2.7K |
2 |
20/12/23 |
20/12/23 |
ASX - By Stock
|
9
|
2.7K
|
2
|
|
ASX - By Stock
|
BOD |
Re:
Ann: Medicinal cannabis supply agreement with Green Farmers
|
|
BH31
|
10 |
3.8K |
3 |
14/12/23 |
14/12/23 |
ASX - By Stock
|
10
|
3.8K
|
3
|
|
ASX - By Stock
|
BOD |
Re:
Ann: Medicinal cannabis supply agreement with Green Farmers
|
|
BH31
|
10 |
3.8K |
1 |
13/12/23 |
13/12/23 |
ASX - By Stock
|
10
|
3.8K
|
1
|
|
ASX - By Stock
|
BOD |
Re:
Ann: Appointment of Voluntary Administrators
|
|
BH31
|
36 |
14K |
4 |
07/12/23 |
07/12/23 |
ASX - By Stock
|
36
|
14K
|
4
|
|
ASX - By Stock
|
BOD |
Re:
Ann: Notice to Shareholders
|
|
BH31
|
7 |
1.8K |
3 |
01/12/23 |
01/12/23 |
ASX - By Stock
|
7
|
1.8K
|
3
|
|
ASX - By Stock
|
BOD |
Re:
Ann: Appointment of Voluntary Administrators
|
|
BH31
|
36 |
14K |
3 |
30/11/23 |
30/11/23 |
ASX - By Stock
|
36
|
14K
|
3
|
|
ASX - By Stock
|
BOD |
Re:
News: BOD Bod Science Seeks Trading Halt
|
|
BH31
|
25 |
5.2K |
1 |
24/11/23 |
24/11/23 |
ASX - By Stock
|
25
|
5.2K
|
1
|
|
ASX - By Stock
|
ME1 |
Re:
Ann: Health House Australia Revenue Update
|
|
BH31
|
28 |
9.4K |
7 |
16/11/23 |
16/11/23 |
ASX - By Stock
|
28
|
9.4K
|
7
|
|
ASX - By Stock
|
OJC |
Re:
Ann: Placement
|
|
BH31
|
33 |
14K |
2 |
16/11/23 |
16/11/23 |
ASX - By Stock
|
33
|
14K
|
2
|
|
ASX - By Stock
|
OJC |
Re:
Ann: Placement
|
|
BH31
|
33 |
14K |
6 |
16/11/23 |
16/11/23 |
ASX - By Stock
|
33
|
14K
|
6
|
|
ASX - By Stock
|
BOD |
Re:
Ann: Bod Science announces placement to raise A$2m
|
|
BH31
|
55 |
11K |
2 |
08/11/23 |
08/11/23 |
ASX - By Stock
|
55
|
11K
|
2
|
|
ASX - By Stock
|
OJC |
Re:
Ann: AGM Address to Shareholders
|
|
BH31
|
5 |
1.7K |
4 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
5
|
1.7K
|
4
|
|
ASX - By Stock
|
BOD |
Re:
Ann: Continuation of Suspension from Quotation
|
|
BH31
|
8 |
1.8K |
1 |
02/11/23 |
02/11/23 |
ASX - By Stock
|
8
|
1.8K
|
1
|
|
ASX - By Stock
|
BOD |
Re:
Ann: Suspension from Quotation
|
|
BH31
|
7 |
1.3K |
3 |
01/11/23 |
01/11/23 |
ASX - By Stock
|
7
|
1.3K
|
3
|
|
ASX - By Stock
|
BOD |
Re:
Ann: Bod completes acquisition of Aqua Phase
|
|
BH31
|
22 |
4.8K |
4 |
11/08/23 |
11/08/23 |
ASX - By Stock
|
22
|
4.8K
|
4
|
|
ASX - By Stock
|
BOD |
Re:
Ann: Trading Halt
|
|
BH31
|
21 |
4.7K |
5 |
02/08/23 |
02/08/23 |
ASX - By Stock
|
21
|
4.7K
|
5
|
|
ASX - By Stock
|
BOD |
Re:
Ann: Completion of Pivotal Aqua Phase PK Studies
|
|
BH31
|
13 |
4.3K |
4 |
25/07/23 |
25/07/23 |
ASX - By Stock
|
13
|
4.3K
|
4
|
|
ASX - By Stock
|
BOD |
Re:
Ann: Phase IIB Clinical Trial of Schedule 3
|
|
BH31
|
17 |
4.0K |
4 |
18/07/23 |
18/07/23 |
ASX - By Stock
|
17
|
4.0K
|
4
|
|
ASX - By Stock
|
BOD |
Re:
Ann: Webinar Invitation
|
|
BH31
|
4 |
1.1K |
4 |
13/07/23 |
13/07/23 |
ASX - By Stock
|
4
|
1.1K
|
4
|
|
ASX - By Stock
|
BOD |
Re:
Ann: Phase IIB Clinical Trial of Schedule 3
|
|
BH31
|
17 |
4.0K |
2 |
11/07/23 |
11/07/23 |
ASX - By Stock
|
17
|
4.0K
|
2
|
|
ASX - By Stock
|
BOD |
Re:
Ann: Updates on Phase IIB clinical trial of Schedule 3 CBD
|
|
BH31
|
13 |
3.2K |
4 |
04/07/23 |
04/07/23 |
ASX - By Stock
|
13
|
3.2K
|
4
|
|
ASX - By Stock
|
BOD |
Re:
Ann: Updates on Phase IIB clinical trial of Schedule 3 CBD
|
|
BH31
|
13 |
3.2K |
3 |
03/07/23 |
03/07/23 |
ASX - By Stock
|
13
|
3.2K
|
3
|
|
ASX - By Stock
|
BOD |
Re:
Ann: BOD and Malaysian Antah Group sign Letter of Intent
|
|
BH31
|
3 |
1.2K |
0 |
22/06/23 |
22/06/23 |
ASX - By Stock
|
3
|
1.2K
|
0
|
|
ASX - By Stock
|
BOD |
Re:
Ann: Updates regarding Aqua Phase Delivery Technology
|
|
BH31
|
14 |
3.8K |
2 |
05/06/23 |
05/06/23 |
ASX - By Stock
|
14
|
3.8K
|
2
|
|
ASX - By Stock
|
OJC |
Re:
Ann: OJC enter export Juice markets
|
|
BH31
|
11 |
5.0K |
1 |
11/05/23 |
11/05/23 |
ASX - By Stock
|
11
|
5.0K
|
1
|
|
ASX - By Stock
|
OJC |
Re:
Ann: OJC enter export Juice markets
|
|
BH31
|
11 |
5.0K |
3 |
09/05/23 |
09/05/23 |
ASX - By Stock
|
11
|
5.0K
|
3
|
|
ASX - By Stock
|
OJC |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
BH31
|
4 |
1.4K |
2 |
01/05/23 |
01/05/23 |
ASX - By Stock
|
4
|
1.4K
|
2
|
|
ASX - By Stock
|
BOD |
Re:
Ann: Change in Chairman's role
|
|
BH31
|
4 |
1.3K |
2 |
24/04/23 |
24/04/23 |
ASX - By Stock
|
4
|
1.3K
|
2
|
|
ASX - By Stock
|
OJC |
Re:
Ann: Conversion of Loan Facility into Equity
|
|
BH31
|
1 |
884 |
4 |
28/03/23 |
28/03/23 |
ASX - By Stock
|
1
|
884
|
4
|
|
ASX - By Stock
|
BOD |
Re:
Ann: Change of Director's Interest Notice - David Baker
|
|
BH31
|
6 |
1.6K |
2 |
23/03/23 |
23/03/23 |
ASX - By Stock
|
6
|
1.6K
|
2
|
|
ASX - By Stock
|
BOD |
Re:
Ann: Appendix 4D and Half Year Account
|
|
BH31
|
29 |
5.1K |
2 |
27/02/23 |
27/02/23 |
ASX - By Stock
|
29
|
5.1K
|
2
|
|
ASX - By Stock
|
BOD |
Re:
Ann: Study highlights efficacy of new medicinal cannabis product
|
|
BH31
|
10 |
5.2K |
1 |
15/07/22 |
15/07/22 |
ASX - By Stock
|
10
|
5.2K
|
1
|
|
ASX - By Stock
|
OJC |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
BH31
|
14 |
8.3K |
5 |
29/04/22 |
29/04/22 |
ASX - By Stock
|
14
|
8.3K
|
5
|
|
ASX - By Stock
|
OJC |
Re:
Ann: Half Yearly Report and Accounts
|
|
BH31
|
29 |
12K |
2 |
11/04/22 |
11/04/22 |
ASX - By Stock
|
29
|
12K
|
2
|
|
ASX - By Stock
|
OJC |
Re:
Carbonated drinks
|
|
BH31
|
6 |
2.0K |
0 |
18/09/21 |
18/09/21 |
ASX - By Stock
|
6
|
2.0K
|
0
|
|
ASX - By Stock
|
OJC |
Carbonated drinks
|
|
BH31
|
6 |
2.0K |
4 |
17/09/21 |
17/09/21 |
ASX - By Stock
|
6
|
2.0K
|
4
|
|
ASX - By Stock
|
OJC |
Re:
Ann: Trading Halt
|
|
BH31
|
37 |
10K |
2 |
12/07/21 |
12/07/21 |
ASX - By Stock
|
37
|
10K
|
2
|
|
ASX - By Stock
|
OJC |
Re:
Ann: Trading Halt
|
|
BH31
|
37 |
10K |
3 |
12/07/21 |
12/07/21 |
ASX - By Stock
|
37
|
10K
|
3
|
|
ASX - By Stock
|
OJC |
Re:
Ann: Trading Halt
|
|
BH31
|
37 |
10K |
4 |
09/07/21 |
09/07/21 |
ASX - By Stock
|
37
|
10K
|
4
|
|
ASX - By Stock
|
OJC |
Re:
Ann: FOD beverage & functional juice business growing at 25.9%
|
|
BH31
|
265 |
54K |
0 |
29/04/21 |
29/04/21 |
ASX - By Stock
|
265
|
54K
|
0
|
|
ASX - By Stock
|
OJC |
Re:
Ann: Quarterly Activities Report
|
|
BH31
|
33 |
9.1K |
1 |
29/04/21 |
29/04/21 |
ASX - By Stock
|
33
|
9.1K
|
1
|
|
ASX - By Stock
|
OJC |
Re:
Ann: FOD beverage & functional juice business growing at 25.9%
|
|
BH31
|
265 |
54K |
0 |
29/04/21 |
29/04/21 |
ASX - By Stock
|
265
|
54K
|
0
|
|
ASX - By Stock
|
OJC |
Re:
Ann: FOD beverage & functional juice business growing at 25.9%
|
|
BH31
|
265 |
54K |
1 |
28/04/21 |
28/04/21 |
ASX - By Stock
|
265
|
54K
|
1
|
|